Immunotherapy

Thursday, January 11, 2018 - 8:00am
Newer targeted treatments like immunotherapy have emerged in recent years and appear to be not only more effective than conventional therapy but also better tolerated, because unlike chemotherapy and radiation, these newer approaches are designed to kill cancer cells without damaging healthy ones.
Tuesday, January 9, 2018 - 8:00am
Judy was diagnosed with stage 4 non-small cell lung cancer in 2016. Almost a year after her diagnosis, with the help of Keytruda, Judy’s tumor has shrunk 95 percent.
Wednesday, December 27, 2017 - 10:00am
The incidence of liver cancer is increasing, making primary liver (and bile duct) cancer the fastest-rising cause of cancer-related death in the United States. Experts attribute this to the high prevalence of fatty liver disease, a condition associated with insulin resistance, obesity, high blood pressure and high cholesterol levels.
Wednesday, October 18, 2017 - 3:45pm
Roswell Park is one of very few institutions in the United States equipped to offer clinical trials of a full range of immunotherapies. How do these treatments work, and what new immunotherapy clinical trials are underway or close to being launched?
Tuesday, October 17, 2017 - 12:48pm
Clinical trials are a key reason why childhood cancer treatments and survival rates have improved significantly in recent years.
Monday, October 16, 2017 - 1:59pm
Dr. Gurkamal Chatta and his colleagues are conducting a phase I clinical trial of an immunotherapy for men with metastatic prostate cancer that has progressed in spite of standard treatment. “We are targeting an area of need where there are really no other effective therapies.”
Thursday, September 28, 2017 - 2:57pm

“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."

Monday, September 25, 2017 - 10:26am

Collected last week from a patient with late-stage ovarian cancer, these are not ordinary T cells; they have been altered and multiplied in the hope that when they are given back to her, they will launch a devastating attack on her cancer cells. 

Thursday, July 13, 2017 - 2:41pm

Read part I of our series about the new complex immunotherapy trials available here at Roswell Park Cancer Institute.

Monday, June 26, 2017 - 1:47pm

I am the Vice Chair for Translational Research in the Department of Medicine and the Director of Cancer Vaccine and Dendritic Cell Therapies in the Center for Immunotherapy. My goal is to fix cancer-related immune dysfunction and teach our bodies to fight cancer.